Sometimes hyped as miracle drugs, even whispered about as elixirs, semaglutide and brand-name variants such as Ozempic and Wegovy are increasingly being taken against obesity and diabetes.But ...

The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to increase oversight of the Medicare Advantage and prescription drug programs for contract year 2026.

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...

Under the proposal, only those who are considered obese — someone who has a body mass index of 30 or higher — would qualify ...

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...